Fertility After Transvaginal Surgery or Uterine Artery Embolization Combined With Uterine Curettage in Patients With Cesarean Scar Pregnancy
Not Applicable
- Conditions
- Magnetic Resonance ImagingOvarian FunctionMenstruation
- Interventions
- Procedure: transvaginal surgery;UAE and D&C
- Registration Number
- NCT02933190
- Lead Sponsor
- Shanghai First Maternity and Infant Hospital
- Brief Summary
To investigate the fertility in patients after treatment by transvaginal surgery or uterine artery embolization combined with uterine curettage
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
- increased levels of serum β-hCG and ultrasonography findings. The criteria for diagnosis by ultrasonography was the presence of the following: (1) an empty uterine cavity and endocervical canal; (2) detection of the placenta and/or a gestational sac embedded in the hysterectomy scar; (3) the presence of the gestation sac with or without a fetal pole and with or without fetal cardiac activity (depending on the gestational age) in the anterior part of the uterine isthmus; and (4) a thin (1-3 mm) or absent myometrial layer between the gestational sac and the bladder(24). All patients had taken Magnetic Resonance Imaging (MRI) to clarify the diagnosis . Pregnancy tissues were identified by histopathology examinations of the surgical tissues.
Read More
Exclusion Criteria
- All enrolled patients had no contraindications for transvaginal surgery or UAE, including renal failure, active pelvic infection, clotting disorders, or known allergy to the contrast material.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description CSP;transvaginal surgery;UAE and D&C transvaginal surgery;UAE and D&C Cesarean scar pregnancy (CSP) refers to the implantation of a gestational sac with the myometrium at the site of a previous cesarean scar
- Primary Outcome Measures
Name Time Method Duration of menstruation by questionnaire (days) six months after treatment Endocrine level by blood examination (FSH in IU/L) six months after treatment Volume of menstruation by questionnaire (in pictorial blood loss score) six months after treatment
- Secondary Outcome Measures
Name Time Method The length of the CSD by MRI (millimeter) six months after treatment The depth of the CSD by MRI (millimeter) six months after treatment The width of the CSD by MRI (millimeter) six months after treatment
Trial Locations
- Locations (1)
Department of Gynecology, Shanghai First Maternity and Infant Hospital, affiliated to Tongji University
🇨🇳Shanghai, Shanghai, China